# Alaunos Therapeutics, Inc. Common Stock (TCRT)

> Alaunos Therapeutics, Inc. Common Stock (TCRT) trades at $1.66 (+4.40%) as of 7:49:43 PM EST on Nov 20, 2026, -45.39% over the past month. Market cap is $4.22M, with 1.0 days to cover in short interest.

Canonical: https://massive.com/quote/tcrt
Data as of: 2026-11-21T00:49:43.348Z (15-minute delayed)
Source: Massive (https://massive.com/docs/llms.txt)

## Price

**$1.66** +0.07 (+4.40%)
At close · 15-minute delayed
Nasdaq · usd

After hours: **$1.63** -0.03 (-1.81%)
As of 7:49:43 PM EST on Nov 20, 2026 · After hours

## Stock performance

How Alaunos Therapeutics, Inc. Common Stock (TCRT) stock has performed from one day to one year, with its 52-week range.

| Period | Return |
| --- | --- |
| 1D | +4.40% |
| 1W | +1.84% |
| 1M | -45.39% |
| YTD | -48.61% |
| 1Y | -50.60% |
| 52-wk range | $0.72 – $4.50 |

From daily closes through Nov 20, 2026.

## Key statistics

Today's trading snapshot for TCRT: day range, open, previous close, volume and market cap.

| Measure | Value |
| --- | --- |
| Day range | $1.61 – $1.75 |
| Open | $1.61 |
| Prev close | $1.59 |
| Volume | 77.55K |
| Market cap | $4.22M |
| Shares out | 4.21M |

## Valuation and profitability ratios

Valuation and profitability ratios for Alaunos Therapeutics, Inc. Common Stock: P/E, P/S, P/B, ROE and more.

| Measure | Value |
| --- | --- |
| P/E | — |
| P/S | 1405.73 |
| P/B | 4.34 |
| P/FCF | — |
| ROE | -399.4% |
| ROA | -202.2% |
| Debt/Equity | 0.00 |
| Div yield | 0.00% |

As of Nov 20, 2026

## Insider trading

[Alaunos Therapeutics, Inc. Common Stock (TCRT) insider trading](https://massive.com/quote/tcrt/insider-trading.md): open-market Form 4 buys and sells by Alaunos Therapeutics, Inc. Common Stock insiders over the last 12 months.

## 8-K filings

Material corporate events Alaunos Therapeutics, Inc. Common Stock has disclosed to the SEC on Form 8-K.

- Oct 23, 2026 · [Listing compliance regained](https://massive.com/quote/sec-filings/8-k/delisting-notices.md)
  “On October 22, 2026, the Company received a letter from Nasdaq's Office of General Counsel advising that the Staff has confirmed that the Company has regained compliance with the Stockholders' Equity Requirement. As a result, Nasdaq has determined that this matter is now closed, the hearing before the Panel scheduled for November 10, 2026 has been cancelled, and the Company's common stock will continue to be listed and traded on The Nasdaq Capital Market.”
- Oct 21, 2026 · [Delisting determination](https://massive.com/quote/sec-filings/8-k/delisting-notices.md)
  “On October 5, 2026, \[the Company\] received a written notice from the Staff informing the Company that its securities were subject to delisting from Nasdaq due to its continued non-compliance with the Stockholders' Equity Requirement unless the Company timely requested a hearing before the Nasdaq Hearings Panel.”
- Oct 13, 2026 · Equity compensation grant
  “On October 12, 2026, the compensation committee of the Board approved the grant to Mr. Weis and Mr. Groenewald of options to purchase 50,000 and 10,000 shares of Common Stock, respectively, at an exercise price of $1.4357 per share.”
- Sep 22, 2026 · Underwriting agreement
  “In connection with the Offering, the Company entered into a Placement Agency Agreement with Dawson James Securities, Inc. as the exclusive placement agent in connection with the Offering. As compensation to the Placement Agent, the Company paid ... a cash fee of 8% of the aggregate gross proceeds raised in the Offering and reimbursed certain expenses.”
- Sep 17, 2026 · Bylaw amendment
  “On September 16, 2026, the Board of Directors of Alaunos Therapeutics, Inc. approved and adopted the Second Amended and Restated By-Laws of the Company, effective immediately. The principal substantive change ... provide\[s\] that the presence in person or by proxy of the holders of one-third (1/3) in voting power of all outstanding shares of stock entitled to vote at a meeting of stockholders constitutes a quorum, rather than a majority.”

## Dividend history and stock splits

Alaunos Therapeutics, Inc. Common Stock's recent dividend payments and stock splits.

### Dividends

No recent dividends.

### Splits

- 1-for-10 · Jul 18, 2024
- 1-for-15 · Feb 1, 2024

## TCRT short interest

How heavily TCRT is shorted: shares short, days to cover and average daily volume.

| Measure | Value |
| --- | --- |
| Days to cover | 1.0 |
| Short interest | 184.37K |
| Avg volume | 7.65M |

As of Oct 30, 2026 · reported to FINRA twice monthly.

## TCRT news

The latest news and headlines about Alaunos Therapeutics, Inc. Common Stock (TCRT).

- [Why C.H. Robinson Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Thursday's Mid-Day Session](https://www.benzinga.com/news/24/02/36895069/why-c-h-robinson-shares-are-trading-lower-by-over-12-here-are-other-stocks-moving-in-thursdays-mid-d) · Benzinga · Feb 1, 2024
- [Why WD-40 Shares Are Trading Higher By Over 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session](https://www.benzinga.com/news/24/01/36581378/why-wd-40-shares-are-trading-higher-by-over-17-here-are-other-stocks-moving-in-wednesdays-mid-day-se) · Benzinga · Jan 10, 2024
- [Why Dermata Therapeutics Shares Are Trading Higher By Over 57%; Here Are 20 Stocks Moving Premarket](https://www.benzinga.com/news/24/01/36508372/why-dermata-therapeutics-shares-are-trading-higher-by-over-57-here-are-20-stocks-moving-premarket) · Benzinga · Jan 5, 2024
- [Why Compugen Shares Are Trading Higher By Over 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session](https://www.benzinga.com/news/23/12/36311961/why-compugen-shares-are-trading-higher-by-over-200-here-are-other-stocks-moving-in-tuesdays-mid-day) · Benzinga · Dec 19, 2023
- [Why Motus GI Holdings Shares Are Trading Lower By Around 46%; Here Are 20 Stocks Moving Premarket](https://www.benzinga.com/news/23/12/36301515/why-motus-gi-holdings-shares-are-trading-lower-by-around-46-here-are-20-stocks-moving-premarket) · Benzinga · Dec 19, 2023

## About Alaunos Therapeutics, Inc. Common Stock

Alaunos Therapeutics Inc is a preclinical-stage biopharmaceutical company focused on the development of novel, orally administered small-molecule therapeutics for obesity and related metabolic disorders, such as metabolic dysfunction-associated steatotic liver disease (MASLD, a type of fatty liver disease). The program aims to develop a differentiated, non-hormonal, non-incretin approach, unlike hormone-based treatments like GLP-1 drugs. It has a single reportable and operating segment related to biopharmaceutical research and development.

| Measure | Value |
| --- | --- |
| Exchange | Nasdaq |
| Market | stocks |
| Type | CS |
| Currency | USD |
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 1 |
| Listed | Aug 24, 2005 |

[Company website](https://www.alaunos.com)

## FAQ

### What is the Alaunos Therapeutics, Inc. Common Stock (TCRT) stock price today?

Alaunos Therapeutics, Inc. Common Stock (TCRT) is trading at $1.66 (+4.40% on the day) as of 7:49:43 PM EST on Nov 20, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.

### What is Alaunos Therapeutics, Inc. Common Stock?

Alaunos Therapeutics Inc is a preclinical-stage biopharmaceutical company focused on the development of novel, orally administered small-molecule therapeutics for obesity and related metabolic disorders, such as metabolic dysfunction-associated steatotic liver disease (MASLD, a…

### What is the short interest in TCRT?

As of Oct 30, 2026, TCRT has 184.37K shares short and 1.0 days to cover.

### What exchange is TCRT listed on?

Alaunos Therapeutics, Inc. Common Stock (TCRT) trades on Nasdaq in USD, in the PHARMACEUTICAL PREPARATIONS industry.

## Live data

Prices here are 15-minute delayed. For real-time TCRT quotes and the full history behind this page, use the Massive API or MCP server:

- `GET https://api.massive.com/v3/snapshot?ticker.any_of=TCRT`

Requests need a Massive API key. API reference for agents: https://massive.com/docs/llms.txt. Connect an AI agent through the Massive MCP server: https://massive.com/docs/ai-tools.

## Related

- [Alaunos Therapeutics, Inc. Common Stock (TCRT) insider trading](https://massive.com/quote/tcrt/insider-trading.md)
- [SEC 8-K events](https://massive.com/quote/sec-filings/8-k.md)
- [Markets overview](https://massive.com/quote/index.md)

Nothing here is investment advice. Data and content are provided for informational purposes under the Massive Terms of Service: https://massive.com/terms
